On the face of it, a non-sensical decision. Cochrane provides resources, platforms, methods, evidence that are relied upon as standard components of health research methodology across several...
On the face of it, a non-sensical decision. Cochrane provides resources, platforms, methods, evidence that are relied upon as standard components of health research methodology across several stages of translation in the UK. It doesn't even make sense in terms of the UK's research funding priorities, which are at present heavily skewed towards health research, such that they can identify technologies to save a struggling NHS, or at least save it money (however misguided or not that may be as a goal).
I am a little unsure about the organisational structure, what the UK branch does specifically, outside of hosting UK-based review groups. Perhaps the play is that they will attempt to continue to benefit from the org, e.g. UK researchers will continue to join review groups hosted elsewhere, register/propose/enact their own reviews, but without paying for or contributing to the provision of the resources/organisational overhead required, relying on the infrastructure funded elsewhere?
The UK's NIHR (National Institute for Health and Care Research) has decided to end the funding for Cochrane UK. This means that if Cochrane UK cannot find a new host, and new funding, they will...
The UK's NIHR (National Institute for Health and Care Research) has decided to end the funding for Cochrane UK. This means that if Cochrane UK cannot find a new host, and new funding, they will close.
On the face of it, a non-sensical decision. Cochrane provides resources, platforms, methods, evidence that are relied upon as standard components of health research methodology across several stages of translation in the UK. It doesn't even make sense in terms of the UK's research funding priorities, which are at present heavily skewed towards health research, such that they can identify technologies to save a struggling NHS, or at least save it money (however misguided or not that may be as a goal).
I am a little unsure about the organisational structure, what the UK branch does specifically, outside of hosting UK-based review groups. Perhaps the play is that they will attempt to continue to benefit from the org, e.g. UK researchers will continue to join review groups hosted elsewhere, register/propose/enact their own reviews, but without paying for or contributing to the provision of the resources/organisational overhead required, relying on the infrastructure funded elsewhere?
The UK's NIHR (National Institute for Health and Care Research) has decided to end the funding for Cochrane UK. This means that if Cochrane UK cannot find a new host, and new funding, they will close.
I've linked to Cochrane UK's press release. Here's a link to the international Cochrane organisation's press release: https://www.cochrane.org/news/news-cochrane-uk NIHR doesn't appear to have said anything yet: https://www.nihr.ac.uk/
I don't understand this decision. Cochrane UK does excellent work. Losing it would be pretty bad for the quality of health research in the UK.